[Federal Register Volume 63, Number 27 (Tuesday, February 10, 1998)]
[Notices]
[Pages 6761-6762]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3295]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Renewals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) announces the renewal
of certain FDA advisory
[[Page 6762]]
committees by the Commissioner of Food and Drugs (the Commissioner).
The Commissioner has determined that it is in the public interest to
renew the charters of the committees listed below for an additional 2
years beyond charter expiration date. The new charters will be in
effect until the dates of expiration listed below. This notice is
issued under the Federal Advisory Committee Act of October 6, 1972
(Pub. L. 92-463 (5 U.S.C. app. 2)).
DATES: Authority for these committees will expire on the dates
indicated below unless the Commissioner formally determines that
renewal is in the public interest.
------------------------------------------------------------------------
Name of committee Date of expiration
------------------------------------------------------------------------
Antiviral Drugs Advisory Committee February 15, 1999
National Mammography Quality Assurance July 6, 1999
Advisory Committee
Nonprescription Drugs Advisory Committee August 27, 1999
Advisory Committee on Special Studies December 2, 1999
Relating to the Possible Long-Term Health
Effects of Phenoxy Herbicides and
Contaminants
Food Advisory Committee December 18, 1999
Vaccines and Related Biological Products December 31, 1999
Advisory Committee
------------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-4820.
Dated: February 4, 1998.
Michael A. Friedman,
Lead Deputy Commissioner for the Food and Drug Administration.
[FR Doc. 98-3295 Filed 2-9-98; 8:45 am]
BILLING CODE 4160-01-F